BIO profile: Queensland Clinical Trials Network

By Staff Writers
Friday, 20 April, 2007

The Queensland Clinical Trials Network (QCTN) is an independent, not-for profit industry association established to promote groups that provide clinical trial or related services in Australia. It now has in excess of 50 members, some of whom will be exhibiting on stand 1607 at BIO 2007.

ERA Consulting - Strategic scientific/regulatory consulting for human medicines. www.eraconsulting.com

BioPharmaceuticals Australia - Queensland Government initiative which aims to develop Australia's contract GMP capability for biotherapeutics in clinical development. www.biopharmaus.com.au

Q-Pharm - Q-Pharm specialises in Phase I, II, bioequivalence and bioavailability studies. www.qpharm.com.au

BioAssayLINK - BioAssayLINK is a low cost, innovative online bioassay matching service that within two days, matches customers' specific bioassay requirements with registered worldwide bioassay service providers. www.bioassaylink.com

Clinical Network Services - Comprehensive services include: full clinical research management services including study design, project management, site monitoring, clinical research consultancy and training. www.clinetserv.com

TetraQ - TetraQ services companies who are developing new drugs and assists with selection or confirmation of drug candidates, with a view to starting clinical trials. www.tetraq.com.au

The Wesley Research Institute - The Institute, an independent, not-for-profit organisation conducts cardiovascular disease, endocrinology, oncology, respiratory and urology trials. www.wesleyresearchinstitute.com.au

Perkins Resources - Perkins Resources merges the expertise of the recruitment industry with the talent of the life science industry. www.perkinsresources.com

Queensland Institute of Medical Research - QIMR scientists are working on novel and strategic technologies with an integrated approach to biomedical research. www.qimr.edu.au

Related News

TGA approves therapy for paediatric growth hormone deficiency

The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...

Immune cell boost could enable lasting vaccine protection

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...

Genes influence when babies start walking

Genetics accounts for about a quarter of the differences in when children take their first steps,...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd